title: The FDA Reevaluates Oral Fluconazole Use in Pregnancy.
authors.affiliation: Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.
authors.forename: Diane S
authors.initials: DS
authors.lastname: Aschenbrenner
mesh_terms: D000022:Abortion, Spontaneous / Q000517:prevention & control; D000284:Administration, Oral; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015725:Fluconazole / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole